Adaptive Randomization of Neratinib in Early Breast Cancer

The treatment of aggressive, locally advanced breast cancers increasingly includes neoadjuvant therapy before surgical resection, thus providing a window of opportunity to tailor treatments on the basis of early assessments of the molecular characteristics of the cancer and their response to…

from Cancer via ola Kala on Inoreader http://ift.tt/29kG44E
via IFTTT